*Richards H, Longhi MP, Wright K, Gallimore A, Ager A: CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity. J Immunol. 2008 Jan 1;180 (1) :198-206., URL: https://www.ncbi.nlm.nih.gov/pubmed/18097020?itool, *Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ: Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood. 2004 Feb 15;103 (4) :1534-41., URL: https://www.ncbi.nlm.nih.gov/pubmed/14551132?itool, *Xu H, Manivannan A, Crane I, Dawson R, Liversidge J: Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation. Blood. 2008 Aug 15;112 (4) :1166-74., URL: https://www.ncbi.nlm.nih.gov/pubmed/18391078?itool, *Friedline RH, Wong CP, Steeber DA, Tedder TF, Tisch R: L-selectin is not required for T cell-mediated autoimmune diabetes. J Immunol. 2002 Mar 15;168 (6) :2659-66., URL: https://www.ncbi.nlm.nih.gov/pubmed/11884430?itool, *Gallatin WM, Weissman IL, Butcher EC: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983 Jul 7;304:30-34., URL: https://www.ncbi.nlm.nih.gov/pubmed/16785489?itool, *Brawand P, Cerottini JC, MacDonald HR: Hierarchal utilization of different T-cell receptor Vbeta gene segments in the CD8 (+) -T-cell response to an immunodominant Moloney leukemia virus-encoded epitope in vivo. J Virol. 1999 Nov;73 (11) :9161-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/10516023?itool, *Fisson S, Darrasse-Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL: Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003 Sep 1;198 (5) :737-46., URL: https://www.ncbi.nlm.nih.gov/pubmed/12939344?itool, *ten Bruggencate SJ, Hillyer LM, Woodward BD: The proportion of CD45RA (+) CD62L (+) (quiescent-phenotype) T cells within the CD8 (+) subset increases in advanced weight loss in the protein- or energy-deficient weanling mouse. J Nutr. 2001 Dec;131 (12) :3266-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/11739878?itool, *Mannering SI, Cheers C: Interleukin-2 and loss of immunity in experimental Mycobacterium avium infection. Infect Immun. 2002 Jan;70 (1) :27-35., URL: https://www.ncbi.nlm.nih.gov/pubmed/11748160?itool, *Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R: The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes. 2007 May;56 (5) :1395-402., URL: https://www.ncbi.nlm.nih.gov/pubmed/17317763?itool, *Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD: Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Int Immunol. 2004 Sep;16 (9) :1283-94., URL: https://www.ncbi.nlm.nih.gov/pubmed/15262898?itool
